Advertisement

Chronic Pain in Head and Neck Cancers

  • Vijay V. Haribhakti
Chapter

Abstract

One of the most distressing realities about advanced Head and Neck cancers is chronic and often unremitting Pain.

Chemotherapy and radiotherapy produce mucositis, ulceration, necrosis, xerostomia and trismus, which in turn lead to severe pain and neuropathy. The degree and persistence of pain depend upon the dose of radiation and the extent of tissue damage.

Pain assumes a variety of manifestations and must be accurately assessed for type and intensity. A scoring system has been described.

A variety of agents are employed for pain relief and their use depends upon analysis of the cause, intensity and persistence.

Although now a specialty in itself, pain relief must be understood by every practitioner of Head and Neck Oncology.

References

  1. 1.
    Foley KM (1985) The treatment of cancer pain. N Engl J Med 313(2):84–95CrossRefGoogle Scholar
  2. 2.
    Foley KM, Inturrisi CE (1987) Analgesic drug therapy in cancer pain: principles and practice. Med Clin North Am 71:207–232CrossRefGoogle Scholar
  3. 3.
    Cleeland CS, Gonin R, Hatfield AK et al (1994) Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 330:592–596CrossRefGoogle Scholar
  4. 4.
    de Wit R, van Dam F, Loonstra S et al (2001) The Amsterdam Pain Management Index compared to eight frequently used outcome measures to evaluate the adequacy of pain treatment in cancer patients with chronic pain. Pain 91:339–349CrossRefGoogle Scholar
  5. 5.
    Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KA, Grond S (2001) Symptoms during cancer pain treatment following WHO guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain 93:247–257CrossRefGoogle Scholar
  6. 6.
    van Wilgen CP, Dijkstra PU, van der Laan BF et al (2004) Morbidity of the neck after head and neck cancer therapy. Head Neck 26:785–791CrossRefGoogle Scholar
  7. 7.
    Evensen JF, Bjordal K, Knutsen BH et al (2002) Side effects and quality of life after inadvertent radiation overdosage in brachytherapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys 52:944–952CrossRefGoogle Scholar
  8. 8.
    Gellrich NC, Schramm A, Bockmann R et al (2002) Follow-up in patients with oral cancer. J Oral Maxillofac Surg 60:380–386CrossRefGoogle Scholar
  9. 9.
    Woolf CJ, Mannion RJ (1999) Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 353(9168):1959–1964CrossRefGoogle Scholar
  10. 10.
    Perkins FM, Kehlet H (2000) Chronic pain as an outcome of surgery. Anesthesiology 93:1123–1133CrossRefGoogle Scholar
  11. 11.
    Sist T, Miner M, Lemma M (1999) Characteristics of postradical neck pain syndrome: a report of 25 cases. J Pain Symptom Manag 18(2):95–102CrossRefGoogle Scholar
  12. 12.
    Grond S, Zech D, Lynch J, Diefenbach C, Schug SA, Lehmann KA (1993) Validation of World Health Organization guidelines for pain relief in head and neck cancer. A prospective study. Ann Otol Rhinol Laryngol 102(5):342–348CrossRefGoogle Scholar
  13. 13.
    Lindenlaub T, Sommer C (2003) Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies. Acta Neuropathol 105(6):593–602PubMedGoogle Scholar
  14. 14.
    Benoleil R, Epstein J, Eliav E, Jurevic R, Elad S (2007) Orofacial pain in Cancer: part I: mechanisms. J Dent Res 86(6):491–505CrossRefGoogle Scholar
  15. 15.
    Coderre TJ, Katz J, Vaccarino AL et al (1993) Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 52(3):259–285CrossRefGoogle Scholar
  16. 16.
    Burton AW, Fanciullo GJ, Beasley RD et al (2007) Chronic pain in the cancer survivor: a new frontier. Pain Med 8(2):189–198CrossRefGoogle Scholar
  17. 17.
    Postma TJ, Vermorken JB, Liefting AJ et al (1995) Paclitaxel- induced neuropathy. Ann Oncol 6(5):489–494CrossRefGoogle Scholar
  18. 18.
    Verstappen CC, Postma TJ, Hoekman K et al (2003) Peripheral neuropathy due to therapy with paclitaxel, gemcitabine, and cisplatin in patients with advanced ovarian cancer. J Neuro-Oncol 63(2):201–205CrossRefGoogle Scholar
  19. 19.
    Lossignol D, Razavi D, Delvaux N (2008) Douleur et analgésie. In: Razavi D, Del-vaux N (eds) Précis de psycho-oncologie de l’adulte. Elsevier Masson, ParisGoogle Scholar
  20. 20.
    McCraken LM, Eccleston C (2003) Coping or acceptance: what to do about chronic pain. Pain 105:197–204CrossRefGoogle Scholar
  21. 21.
    Siddall PJ, Cousins MJ (2004) Persistent pain as a disease entity: implications for clinical management. Anesth Analg 99:510–520CrossRefGoogle Scholar
  22. 22.
    Paice JA, Portenoy R, Lacchetti C, Campbell T, Cheville A, Citron M, Constine LS, Cooper A, Glare P, Keefe F, Koyyalagunta L (2016) Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice guideline. J Clin Oncol 34(27):3325–3345CrossRefGoogle Scholar
  23. 23.
    Novy D, Berry MP, Palmer JL et al (2005) Somatic symptoms in patients with chronic non-cancer related and cancer-related pain. J Pain Symptom Manag 29:603–612CrossRefGoogle Scholar
  24. 24.
    Martinez V et al (2010) Les douleurs neuropathiques chroniques. Guidelines de laSFETD. Douleurs 11:3–21Google Scholar
  25. 25.
    McNeely ML, Paliament M, Courneya KS et al (2004) A pilot study of a randomized controlled trial to evaluate the effects of progressive resistance exercise training on shoulder dysfunction caused by spinal accessory neurapraxia/neurectomy in head and neck cancer survivors. Head Neck 26:518–530CrossRefGoogle Scholar
  26. 26.
    Linton SJ, Boersma K, Jansson M et al (2005) The effects of cognitive-behavioral and physical therapy preventive interventions on pain-related sick leave: a randomized controlled trial. Clin J Pain 21:109–119CrossRefGoogle Scholar
  27. 27.
    Gonzales GR, Elliott KJ, Portenoy RK, Foley KM (1991) The impact of a comprehensive evaluation in the management of cancer pain. Pain 47:141–144CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Vijay V. Haribhakti
    • 1
  1. 1.Department of OncologySir HN Reliance Foundation HospitalMumbaiIndia

Personalised recommendations